96 The Effect of Individualized Intravenous Heparin Dosing on Activated Partial Thromboplastin Time Values in Neurocritical Care Patients

Introduction: At the University of Illinois Hospital & Health Sciences System (UI Health), patients at high risk for bleeding, such as neurocritical care patients, may receive individualized IV heparin therapy. This non-standardized approach may cause aPTT value variability, resulting in serious adverse events (e.g., thrombosis and hemorrhage). This study aims to determine the effects of individualized IV heparin dosing on aPTT values.